Stockholm - Delayed Quote • SEK
Boule Diagnostics AB (publ) (BOUL.ST)
At close: April 25 at 5:29 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jesper Soderqvist Ph.D. | President, CEO & MD | 3.83M | -- | 1966 |
| David Metrena | Senior Vice President of Commercial Operations of US | -- | -- | -- |
Boule Diagnostics AB (publ)
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 228
Description
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Corporate Governance
Boule Diagnostics AB (publ)’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 1; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- May 06, 2022Ex-Dividend Date
Upcoming Events
May 07, 2024
Boule Diagnostics AB (publ) Earnings Call
Related Tickers
688389.SS Shenzhen Lifotronic Technology Co., Ltd.
19.70
+4.01%
MNTC.ST Mentice AB (publ)
36.40
-0.82%
CEVI.ST CellaVision AB (publ)
229.50
-4.37%
EKF.L EKF Diagnostics Holdings plc
27.80
+0.18%
300760.SZ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
287.56
+0.86%
BICO.ST BICO Group AB (publ)
44.32
-0.67%
QTRX Quanterix Corporation
15.59
-2.81%
CHEMM.CO ChemoMetec A/S
282.40
-0.77%
BIO Bio-Rad Laboratories, Inc.
275.60
-0.94%
PACB Pacific Biosciences of California, Inc.
1.3800
+1.47%